Sam Kim, MD
Otolaryngology · Fairbanks, AKNPI 1851454615
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $866 of the $1,352 with a category attached, or 64.0%. 10 manufacturers reported payments, led by Stryker at 43.6% of the total. Reporting peaked in 2019 at $573 and has fallen 80.9% since, to $110 in 2025.
Across 37 payments — averaging $36.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$590
- GSK$316
- Sanofi$141
- Inspire Medical Systems, Inc.$132
- Biocryst US Sales Co., LLC$41
- Medtronic$41
- plus $91 from 4 others
What the payments were for
- Travel & lodging$48636%
- Food & beverage$86664%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 10 | $590 |
| GSK | 15 | $316 |
| Sanofi | 5 | $141 |
| Inspire Medical Systems, Inc. | 1 | $132 |
| Biocryst US Sales Co., LLC | 1 | $41 |
| Medtronic | 1 | $41 |
| Boston Scientific | 1 | $34 |
| Intersect ENT, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Jubilant Hollisterstier LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,352 in reported general payments places this provider in the 55th percentile of 20 otolaryngology providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 87 | $2,918 |
| Fluocinolone Acetonide Oil | 26 | $1,065 |
| Omeprazole | 31 | $927 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $857 |
| Fluticasone Propionate | 67 | $634 |
| Famotidine | 52 | $512 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 27 | $284 |
| Duloxetine Hcl | 17 | $233 |
| Mupirocin | 33 | $195 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Fairbanks
- Thomas HammondFairbanks$4K
- Eugene SansoniWasilla$8K
- Jennifer MitchellWasilla$5K
- Jerome ListEagle River$4K
- Stephen SchafferAnchorage$2K
- Eli BressAnchorage$2K
- Khang LuAnchorage$2K
- Christopher KowalskiAnchorage$2K
- Mark LorenzAnchorage$1K
- John KokeshAnchorage$604
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.